Új vizsgálatok, publikációk, preprintek és pályázatok ezen a célponton, hónapról hónapra.
Vizsgálat
Effect of Atogepant on the Vestibulo-Ocular Reflex in Healthy Adults and Adults With Migraine
2027. jan. 1.· PHASE4 · NOT_YET_RECRUITING· CTGOV
Publikáció
Critical comparison of ELISA kits for CGRP measurements in migraine.
2026. nov. 5.· Headache· PUBMED
Publikáció
CGRP levels in autoimmune diseases: a systematic review and meta-analysis of its potential role as a biomarker.
2026. nov. 3.· Biomarkers in medicine· PUBMED
Publikáció
Real-World Effectiveness and Utilisation of Anti-CGRP Monoclonal Antibodies for Migraine Prevention in a Public Healthcare System.
2026. nov. 3.· Drugs - real world outcomes· PUBMED
Publikáció
The role of neurogenic inflammation and CGRP in migraine headache.
2026. nov. 2.· British journal of pharmacology· PUBMED
Publikáció
[CGRP-targeted drugs in chronic migraine prophylaxis: comparing efficacy and tolerability.].
2026. nov. 1.· Recenti progressi in medicina· PUBMED
Publikáció
Development of a machine learning (ML) model to predict 3-month response to CGRP monoclonal antibodies in migraine: A pilot evaluation of physician-ML model interaction.
2026. okt. 28.· Headache· PUBMED
Publikáció
Longitudinal effects of CGRP-targeting migraine therapies on blood pressure and body mass index: A 12-month retrospective analysis.
2026. okt. 25.· Headache· PUBMED
Publikáció
Sensory neuron-derived CGRP ameliorates kidney injury and fibrosis via monocytes and macrophages.
2026. okt. 23.· Cell research· PUBMED
Publikáció
A Systematic Review of the Role of Monoclonal Antibodies as CGRP Inhibitors in Preventing Chronic and Episodic Migraine.
2026. okt. 20.· CNS & neurological disorders drug targets· PUBMED
Publikáció
Changes in plasma CGRP levels and clinical outcomes following acupuncture in episodic migraine: a prospective pilot study (the AcuCGRP study).
2026. okt. 16.· Frontiers in neurology· PUBMED
Publikáció
CGRP-RAMP1/CALCRL Signaling Drives TGF-β2-Mediated Immune Evasion and Pancreatic Cancer Progression.
2026. okt. 14.· International journal of molecular sciences· PUBMED
Vizsgálat
Efficacy of Rimegepant 75 mg for the Acute Treatment of Migraine: a Bayesian Individual Participant Data Meta-analysis Standardized to Defined Target Populations
2026. okt. 12.· NA · ACTIVE_NOT_RECRUITING· CTGOV
Publikáció
Early Pregnancy Use of Anti-CGRP Monoclonal Antibodies and Propranolol and Spontaneous Abortion Risk.
2026. okt. 12.· JAMA neurology· PUBMED
Publikáció
Preliminary evidence of long-term safety and effectiveness of anti-CGRP drugs for migraine prevention in people with comorbid epilepsy: A 52-week follow-up retrospective study.
2026. okt. 9.· Epilepsia open· PUBMED
Publikáció
Same trials, different answers: reconciling four meta-analyses of anti-CGRP antibodies in cluster headache.
2026. okt. 9.· Pain management· PUBMED
Publikáció
Bushen Huoxue Formula promotes osteoporotic fracture healing by CGRP-mediated dual regulation of BMSCs-osteoclasts balance through modulating mitochondrial energy metabolism.
2026. okt. 7.· Phytomedicine : international journal of phytotherapy and phytopharmacology· PUBMED
Vizsgálat
Psychological Support for Chronic Migraine Patients Treated With Anti-CGRP (Anti-Calcitonin Gene-Related Peptide ) Monoclonal Antibodies
2026. okt. 1.· NA · NOT_YET_RECRUITING· CTGOV
Vizsgálat
Rimegepant-Sensitized Neoadjuvant Chemoimmunotherapy for Oral or Oropharyngeal Squamous Cell Carcinoma
2026. okt. 1.· PHASE2 · NOT_YET_RECRUITING· CTGOV
Publikáció
CGRP remodels the acidic microenvironment and promotes pancreatic carcinoma progression by regulating NHE1 and CA9.
2026. okt. 1.· Frontiers in pharmacology· PUBMED
Publikáció
Calcitonin Gene-Related Peptide (CGRP) in Bone Repair and Musculoskeletal Pain: A Scoping Review of Skeletal Regeneration, Joint and Tendon Involvement, and CGRP-Targeted Therapies.
2026. okt. 1.· Calcified tissue international· PUBMED
Vizsgálat
Tear Biomarkers for Migraine
2026. szept. 30.· NA · NOT_YET_RECRUITING· CTGOV
Publikáció
Persistence and Reasons for Treatment Discontinuation of Anti-CGRP Therapies in Migraine Prophylaxis: A Systematic Review and Meta-analysis of Real-World Studies.
2026. szept. 30.· Pain and therapy· PUBMED
Publikáció
Guest editorial on "Anti-CGRP treatments in women's health: Gaps and clinical evidence in menstrual migraine, pregnancy, lactation, and hormonal contraception".
2026. szept. 29.· Headache· PUBMED
Publikáció
Tear fluid CGRP changes in epilepsy - evidence from an exploratory pilot study.
2026. szept. 23.· Seizure· PUBMED
Publikáció
The CGRP-nociceptor axis in cancer: tumor-specific programs of immune evasion, stromal remodeling, and tumor growth.
2026. szept. 22.· Frontiers in oncology· PUBMED
Publikáció
Real-World Effectiveness and Safety of Anti-CGRP Monoclonal Antibodies in the Prevention of High-Frequency Episodic and Chronic Migraine in Romania-A Multicenter Retrospective Observational Study.
2026. szept. 20.· Biomedicines· PUBMED
Vizsgálat
Biological Profiles of Neuropeptides, Neurotrophins and miRNA in Migraine
2026. szept. 17.· NA · NOT_YET_RECRUITING· CTGOV
Publikáció
Resistance training for migraine in females: mechanistic review of hormonal, CGRP, autonomic, vascular, and nociceptive pathways.
2026. szept. 17.· Journal of neurophysiology· PUBMED
Publikáció
Long-term safety of CGRP pathway inhibitors in migraine patients with prior cerebrovascular or cardiovascular disease.
2026. szept. 15.· Journal of neurology· PUBMED